Correspondence on 'Impact of the COVID-19 pandemic on the disease course of patients with inflammatory rheumatic diseases: results from the Swiss Clinical Quality Management cohort'.

Ruyssen-Witrand, Adeline; Soubrier, Martin; Basch, André; Truchetet, Marie-Elise; Seror, Raphaèle

Ruyssen-Witrand, Adeline; Soubrier, Martin; Basch, André; Truchetet, Marie-Elise; Seror, Raphaèle.

Ruyssen-Witrand A; Purpan Teaching Hospital, Rheumatology, University Hospital Centre Toulouse, Toulouse, France adruyssen@hotmail.com.
Soubrier M; Rheumatology, G. Montpied Hospital, Clermont-Ferrand, France.
Basch A; Clinique Protestante de Lyon, Lyon, France.
Truchetet ME; Rhumatologie, CHU Bordeaux, Bordeaux, France.
Seror R; Rheumatology Department, Université Paris Sud, Hôpitaux Universitaires Paris-Sud, AP-HP, INSERM UMR 1184, Le Kremlin-Bicêtre, France.

Ann Rheum Dis ; 2020 Nov 11.

Article in English | MEDLINE | ID: covidwho-2279075

Keywords

arthritis; biological therapy; epidemiology; health care; quality indicators; rheumatoid

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study Language: English Year: 2020 Document Type: Article Affiliation country: Annrheumdis-2020-219409

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google